Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads

10.18632/oncotarget.9579

Saved in:
Bibliographic Details
Main Authors: Kaminska, K.K, Bertrand, H.C, Tajima, H, Stafford, W.C, Cheng, Q, Chen, W, Wells, G, Arner, E.S.J, Chew, E.-H
Other Authors: PHARMACY
Format: Article
Published: Impact Journals LLC 2020
Subjects:
rat
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175457
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-175457
record_format dspace
spelling sg-nus-scholar.10635-1754572024-04-05T09:03:16Z Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads Kaminska, K.K Bertrand, H.C Tajima, H Stafford, W.C Cheng, Q Chen, W Wells, G Arner, E.S.J Chew, E.-H PHARMACY antineoplastic agent apoptosis signal regulating kinase 1 caspase 3 glutathione peroxidase glutathione reductase indolin 2 one derivative mitogen activated protein kinase p38 nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase oxidoreductase inhibitor selenocysteine stress activated protein kinase thioredoxin unclassified drug antineoplastic agent antioxidant glutathione peroxidase glutathione reductase indole derivative indolin-2-one juglone naphthoquinone reactive oxygen metabolite recombinant protein selenocysteine thioredoxin thioredoxin reductase TXN protein, human antineoplastic activity apoptosis Article breast carcinoma carboxy terminal sequence colorectal cancer drug selectivity drug structure drug targeting electrophilicity enzyme activation enzyme active site enzyme inhibition enzyme metabolism HCT116 cell line human human cell MCF 7 cell line oxidative stress protein cleavage signal transduction animal antagonists and inhibitors bovine chemistry drug design drug screening fibroblast HCT 116 cell line IC50 MCF-7 cell line metabolism mouse protein domain rat Animals Antineoplastic Agents Antioxidants Catalytic Domain Cattle Drug Design Drug Screening Assays, Antitumor Fibroblasts Glutathione Peroxidase Glutathione Reductase HCT116 Cells Humans Indoles Inhibitory Concentration 50 MCF-7 Cells Mice Naphthoquinones Oxidative Stress Protein Domains Rats Reactive Oxygen Species Recombinant Proteins Selenocysteine Thioredoxin-Disulfide Reductase Thioredoxins 10.18632/oncotarget.9579 Oncotarget 7 26 40233-40251 2020-09-10T01:45:29Z 2020-09-10T01:45:29Z 2016 Article Kaminska, K.K, Bertrand, H.C, Tajima, H, Stafford, W.C, Cheng, Q, Chen, W, Wells, G, Arner, E.S.J, Chew, E.-H (2016). Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads. Oncotarget 7 (26) : 40233-40251. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.9579 19492553 https://scholarbank.nus.edu.sg/handle/10635/175457 Impact Journals LLC Unpaywall 20200831
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic antineoplastic agent
apoptosis signal regulating kinase 1
caspase 3
glutathione peroxidase
glutathione reductase
indolin 2 one derivative
mitogen activated protein kinase p38
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
oxidoreductase inhibitor
selenocysteine
stress activated protein kinase
thioredoxin
unclassified drug
antineoplastic agent
antioxidant
glutathione peroxidase
glutathione reductase
indole derivative
indolin-2-one
juglone
naphthoquinone
reactive oxygen metabolite
recombinant protein
selenocysteine
thioredoxin
thioredoxin reductase
TXN protein, human
antineoplastic activity
apoptosis
Article
breast carcinoma
carboxy terminal sequence
colorectal cancer
drug selectivity
drug structure
drug targeting
electrophilicity
enzyme activation
enzyme active site
enzyme inhibition
enzyme metabolism
HCT116 cell line
human
human cell
MCF 7 cell line
oxidative stress
protein cleavage
signal transduction
animal
antagonists and inhibitors
bovine
chemistry
drug design
drug screening
fibroblast
HCT 116 cell line
IC50
MCF-7 cell line
metabolism
mouse
protein domain
rat
Animals
Antineoplastic Agents
Antioxidants
Catalytic Domain
Cattle
Drug Design
Drug Screening Assays, Antitumor
Fibroblasts
Glutathione Peroxidase
Glutathione Reductase
HCT116 Cells
Humans
Indoles
Inhibitory Concentration 50
MCF-7 Cells
Mice
Naphthoquinones
Oxidative Stress
Protein Domains
Rats
Reactive Oxygen Species
Recombinant Proteins
Selenocysteine
Thioredoxin-Disulfide Reductase
Thioredoxins
spellingShingle antineoplastic agent
apoptosis signal regulating kinase 1
caspase 3
glutathione peroxidase
glutathione reductase
indolin 2 one derivative
mitogen activated protein kinase p38
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
oxidoreductase inhibitor
selenocysteine
stress activated protein kinase
thioredoxin
unclassified drug
antineoplastic agent
antioxidant
glutathione peroxidase
glutathione reductase
indole derivative
indolin-2-one
juglone
naphthoquinone
reactive oxygen metabolite
recombinant protein
selenocysteine
thioredoxin
thioredoxin reductase
TXN protein, human
antineoplastic activity
apoptosis
Article
breast carcinoma
carboxy terminal sequence
colorectal cancer
drug selectivity
drug structure
drug targeting
electrophilicity
enzyme activation
enzyme active site
enzyme inhibition
enzyme metabolism
HCT116 cell line
human
human cell
MCF 7 cell line
oxidative stress
protein cleavage
signal transduction
animal
antagonists and inhibitors
bovine
chemistry
drug design
drug screening
fibroblast
HCT 116 cell line
IC50
MCF-7 cell line
metabolism
mouse
protein domain
rat
Animals
Antineoplastic Agents
Antioxidants
Catalytic Domain
Cattle
Drug Design
Drug Screening Assays, Antitumor
Fibroblasts
Glutathione Peroxidase
Glutathione Reductase
HCT116 Cells
Humans
Indoles
Inhibitory Concentration 50
MCF-7 Cells
Mice
Naphthoquinones
Oxidative Stress
Protein Domains
Rats
Reactive Oxygen Species
Recombinant Proteins
Selenocysteine
Thioredoxin-Disulfide Reductase
Thioredoxins
Kaminska, K.K
Bertrand, H.C
Tajima, H
Stafford, W.C
Cheng, Q
Chen, W
Wells, G
Arner, E.S.J
Chew, E.-H
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
description 10.18632/oncotarget.9579
author2 PHARMACY
author_facet PHARMACY
Kaminska, K.K
Bertrand, H.C
Tajima, H
Stafford, W.C
Cheng, Q
Chen, W
Wells, G
Arner, E.S.J
Chew, E.-H
format Article
author Kaminska, K.K
Bertrand, H.C
Tajima, H
Stafford, W.C
Cheng, Q
Chen, W
Wells, G
Arner, E.S.J
Chew, E.-H
author_sort Kaminska, K.K
title Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
title_short Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
title_full Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
title_fullStr Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
title_full_unstemmed Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
title_sort indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
publisher Impact Journals LLC
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/175457
_version_ 1800914371324411904